Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
378.36
+0.68 (0.18%)
Jul 27, 2026, 4:00 PM EDT - Market closed

Elevance Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
198,718197,584175,204170,209155,660136,943
Revenue Growth
5.76%12.77%2.94%9.35%13.67%13.36%
Gross Profit
28,01728,18327,88728,58625,98323,477
Operating Income
4,9056,5717,2827,6147,5167,118
Net Income
4,9635,6625,9805,9875,8946,158
Earnings Per Share
22.5025.2125.6825.2224.2824.95
EPS Growth
-4.25%-1.83%1.82%3.87%-2.69%38.77%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Health Benefits
169,291167,094150,275148,571138,484121,728
CarelonRx
44,49143,40035,961---
Carelon Services
29,67928,31617,961---
Corporate & Other
7646330947939995
Revenue (Total)
198,718197,584175,204170,209155,660136,943

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37,51436,11534,68136,36934,29233,028
Total Debt
31,04432,04631,23225,12024,11423,031
Net Cash (Debt)
6,4704,0693,44911,24910,1789,997
Net Cash Growth
40.47%17.98%-69.34%10.52%1.81%-6.55%
Net Cash Per Share
29.2818.1214.8147.3841.9240.51

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7,4644,2905,8088,0618,3998,364
Capital Expenditures
-1,175-1,116-1,256-1,296-1,152-1,087
Free Cash Flow
6,2893,1744,5526,7657,2477,277
Free Cash Flow Growth
17.84%-30.27%-32.71%-6.65%-0.41%-24.72%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
14.10%14.26%15.92%16.79%16.69%17.14%
Operating Margin
2.47%3.33%4.16%4.47%4.83%5.20%
Pretax Margin
2.95%3.40%4.51%4.53%4.88%5.84%
Profit Margin
2.49%2.87%3.41%3.52%3.78%4.49%
FCF Margin
3.16%1.61%2.60%3.97%4.66%5.31%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
6.8806.8406.5205.9205.1204.520
Dividend Per Share Growth
1.63%4.91%10.13%15.63%13.27%18.95%
Dividend Yield
1.82%1.95%1.76%1.25%1.00%0.98%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.8413.9114.3718.7021.1318.58
Forward PE
13.9713.0911.2513.1716.1416.70
P/FCF Ratio
13.0524.3818.4416.2516.8415.40
PS Ratio
0.410.390.480.650.780.82